MedTrace Logo

Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation

NCT03261934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-12-29

No results posted yet for this study

Summary

Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG malignant transformation events combining TCM indicators with modern medicine indicators. The proposed study is a registry study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 study patients diagnosed with CAG will be recruited. 10-year follow-ups are carried out on-site in hospitals and off-site by telephone to track malignant transformation events.

Conditions

  • Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • The University of Science and Technology of China

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Beijing University of Chinese Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03261934 on ClinicalTrials.gov